Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.53.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.53.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.53.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.53.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.53.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.53.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.53.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.53.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDQ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDQ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XDQ.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDQ.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDQ.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDQ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDQ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HV.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HV.1.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HV.1.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HV.1.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HV.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KA.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KA.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KA.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KA.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HV.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HV.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HV.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HV.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HV.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KH.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used